Article Sidebar
Published:
Jun 22, 2005Article Details
Issue
Section
Articles
Material submitted for publication in the South African Journal of Obstetrics and Gynaecologyl (SAJOG) is accepted provided it has not been published elsewhere. Copyright forms will be sent with acknowledgement of receipt and the SAJOG reserves copyright of the material published.
The SAJOG does not hold itself responsible for statements made by the authors.
Main Article Content
Oestrogen supplementation in gamete intrafallopian transfer (GIFT) — a prospective randomised study
Abstract
Objective. To investigate the impact of oestrogen supplementation from the early luteal to the late proliferative phase on biochemical and ongoing pregnancy rates in gamete intrafallopian transfer (GIFT).
Methods. Ninety-five patients were assigned to clomiphene citrate-human menopausal gonadotrophin (hMG)-induced GIFT cycles, with or without the use of oestrogen support (oral administration of estradiol valerate). The main outcome measures were biochemical pregnancy rate and clinical pregnancy rate.
Results. The biochemical pregnancy rate was 38.09% in the oestrogen group v. 22.9% in the control group (p = 0.096, 95% CI: 5.7 - 37.3%). The clinical pregnancy rate in the oestrogen supplementation group was 23.8% v. 14.58% in the control group (p = 0.1988, 95% CI: 10.3 - 31.7%).
Conclusion. Although the results of this study show no significant statistical difference, there is a clinical trend in favour of giving oestrogen support.
South African Journal of Obstetrics and Gynaecology Vol.11(1) 2005: 6-8
Methods. Ninety-five patients were assigned to clomiphene citrate-human menopausal gonadotrophin (hMG)-induced GIFT cycles, with or without the use of oestrogen support (oral administration of estradiol valerate). The main outcome measures were biochemical pregnancy rate and clinical pregnancy rate.
Results. The biochemical pregnancy rate was 38.09% in the oestrogen group v. 22.9% in the control group (p = 0.096, 95% CI: 5.7 - 37.3%). The clinical pregnancy rate in the oestrogen supplementation group was 23.8% v. 14.58% in the control group (p = 0.1988, 95% CI: 10.3 - 31.7%).
Conclusion. Although the results of this study show no significant statistical difference, there is a clinical trend in favour of giving oestrogen support.
South African Journal of Obstetrics and Gynaecology Vol.11(1) 2005: 6-8
